Regeneron Pharmaceuticals Files 8-K on Financials

Ticker: REGN · Form: 8-K · Filed: Apr 8, 2026 · CIK: 0000872589

Regeneron Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyRegeneron Pharmaceuticals, Inc. (REGN)
Form Type8-K
Filed DateApr 8, 2026
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-results, 8-k

Related Tickers: REGN

TL;DR

REGN filed an 8-K on 4/8/26 with financial updates.

AI Summary

Regeneron Pharmaceuticals, Inc. filed an 8-K on April 8, 2026, reporting results of operations and financial condition. The filing includes various XBRL documents detailing financial information for the period ending April 8, 2026. The company's mailing and business address is 777 Old Saw Mill River Road, Tarrytown, NY 10591.

Why It Matters

This 8-K filing provides investors with crucial updates on Regeneron's financial performance and operational status as of April 8, 2026.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting financial results and does not indicate any unusual or significant risks.

Key Players & Entities

  • REGENERON PHARMACEUTICALS, INC. (company) — Filer
  • 0000872589 (company) — CIK
  • 2026-04-08 (date) — Filing Date and Period of Report
  • 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 (location) — Mailing and Business Address

FAQ

What type of report is this 8-K filing?

This is a Current Report on Form 8-K, filed by Regeneron Pharmaceuticals, Inc.

When was this 8-K filing accepted by the SEC?

The filing was accepted on April 8, 2026, at 07:05:58.

What is the CIK number for Regeneron Pharmaceuticals, Inc.?

The CIK number for Regeneron Pharmaceuticals, Inc. is 0000872589.

What is the business address of Regeneron Pharmaceuticals, Inc.?

The business address is 777 Old Saw Mill River Road, Tarrytown, NY 10591.

What specific item is reported in this 8-K filing?

This 8-K filing reports on Item 2.02: Results of Operations and Financial Condition.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2026 regarding REGENERON PHARMACEUTICALS, INC. (REGN).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.